🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT06574282
Recruiting Observational

Characteristics of Hypophosphatasia in Adult Patients in Rheumatology and Their Value in Developing an Algorithm to HPP-diagnosis - the COHIR Multi-center Study

NCT06574282 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2024-08-25
Last updated
2025-02-10

Condition(s) studied

Hypophosphatasia

Investigational drug(s) / intervention(s)

Second alkaline phosphatase measurement

Second alkaline phosphatase measurement: (1-4 weeks after the 1st measurement)

Study summary

Non-interventional, prospective, multi-center investigation with exploratory data analysis to assess the proportion of patients with hypophosphatasia presenting at departments of rheumatology and to establish an algorithm to HPP diagnosis

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Written informed consent * Age \> 18 years * Clinical suspicion of hypophosphatasia * Evidence of an abnormal ALP (ALP below LLN) within the clinical routine screening Exclusion Criteria: * Failure to meet the inclusion criteria listed above

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Clinic of Internal Medicine III, Department of Oncology, Haematology, Rheumatology and Clinical Immunology, University Hospital Bonn Bonn North Rhine-Westphali Recruiting

More University of Bonn trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06574282 on ClinicalTrials.gov ↗ ← All trials in Germany